Article
Germline testing and genetic counselling in prostate cancer.
Nature reviews. Urology - 1 Jun 2022
Russo Jessica, Giri Veda N
Abstract excerpt
Genetic testing for prostate cancer is rapidly growing and is increasingly being driven by precision medicine. Rates of germline pathogenic variants have been reported in up to 15% of men with prostate cancer, particularly in metastatic disease, and results of genetic testing could uncover options for precision therapy along with a spectrum of hereditary cancer-predisposition syndromes with unique clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
